iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionGreat Valley Advisor Group, Inc.
Latest Disclosed Ownership3,356 shares
Latest Disclosed Value $ 566,579
Great Valley Advisor Group, Inc. reports 53.59% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 11, 2026 - Great Valley Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 3,356 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $566,579 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,185 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 53.59% during the quarter. The current value of the position is $439,804 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,356 1,171 53.59 567 53.39 0.0103
2026-02-12 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,185 -1,228 -35.98 369 -25.15 0.0071
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,413 -349 -9.28 493 3.79 0.0099
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,762 -1,916 -33.74 475 -34.48 0.0105
2025-05-08 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,678 27 0.48 726 -2.95 0.0156
2025-02-24 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,651 -837 -12.90 747 -20.87 0.0167
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,488 -2 -0.03 945 6.07 0.0232
2024-07-16 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,490 -6,621 -50.50 891 -50.53 0.0249
2024-05-06 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,111 10,325 370.60 1,799 375.93 0.0546
2024-02-06 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,786 344 14.09 378 26.85 0.0133
2023-11-07 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,442 -963 -28.28 299 -31.02 0.0124
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,405 -411 -10.77 432 -12.37 0.0181
2023-05-03 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,816 -28 -0.73 493 -2.18 0.0230
2023-02-01 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,844 214 5.90 504 18.87 0.0258
2022-10-21 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,630 -302 -7.68 424 -8.42 0.0237
2022-07-19 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,932 2,300 140.93 463 94.54 0.0254
2022-04-20 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,632 -158 -8.83 238 -16.20 0.0139
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,790 -1,411 -44.08 284 -45.17 0.0175
2021-10-14 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,201 -259 -7.49 518 -5.47 0.0357
2021-07-27 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,460 598 20.89 548 27.15 0.0405
2021-04-20 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,862 -32 -1.11 431 -1.60 0.0415
2021-01-29 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,894 243 9.17 438 22.01 0.0453
2020-10-21 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,651 -7 -0.26 359 -1.10 0.0441
2020-07-31 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,658 701 35.82 363 72.04 0.0594
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,957 0 0.00 211 -10.21 0.0559
2020-02-10 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,957 -150 -7.12 235 11.90 0.0523
2019-10-25 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,107 -164 -7.22 210 -15.32 0.0507
2019-07-30 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,271 475 26.45 248 23.38 0.0623
2019-04-26 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,796 1,796 201 0.0640
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.